Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd., a leader in 3D-printed regenerative medical implants, has successfully closed its entitlement and shortfall offers, raising A$2.9 million before costs, with a 95% shareholder uptake. This capital boost is aimed at reinforcing the company’s balance sheet, continuing its sales growth, and funding product development, regulatory approvals, and potential strategic acquisitions. The funding comes on the heels of the company’s fifth consecutive quarter of revenue growth, marking a 76% increase year-on-year.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
